Back
Nuveen Dow 30sm Dynamic Overwrite Fund Vs. Astrana Health Industry Stock Comparison
Buy
62
DIAX
Nuveen Dow 30sm Dynamic Overwrite Fund
Last Price:
15.27
Seasonality Move:
-0.68%
Sell
11
ASTH
Astrana Health
Last Price:
41.9300
Seasonality Move:
25.02%
Buy
62
Nuveen Dow 30sm Dynamic Overwrite Fund (DIAX)
is a Buy
Is Nuveen Dow 30sm Dynamic Overwrite Fund a Buy, Sell or Hold?
- The current Nuveen Dow 30sm Dynamic Overwrite Fund [DIAX] share price is $15.30. The Score for DIAX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- DIAX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
11
Astrana Health (ASTH)
is a Sell
Is Astrana Health a Buy, Sell or Hold?
- The current Astrana Health [ASTH] share price is $42.9300. The Score for ASTH is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- ASTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
DIAX Stock Price Chart
What is Nuveen Dow 30sm Dynamic Overwrite Fund's stock price today?
-
The Nuveen Dow 30sm Dynamic Overwrite Fund share price today is $15.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DIAX is experiencing slight selling pressure.
ASTH Stock Price Chart
What is Astrana Health's stock price today?
-
The Astrana Health share price today is $42.9300
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASTH is experiencing selling pressure, which indicates risk of future bearish movement.
DIAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 67.59 | Buy |
| Chaikin Money Flow: | -16167 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.75 - 15.17) | Buy |
| Bollinger Bands (100): | (14.1 - 14.9) | Buy |
ASTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.01 | Sell |
| Relative Strength Index (14 RSI): | 27.01 | Sell |
| Chaikin Money Flow: | -465704 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.464 - 60.504) | Sell |
| Bollinger Bands (100): | (44.6431 - 56.9831) | Sell |
DIAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.03 | Buy |
| 20-day SMA: | 14.94 | Buy |
| 50-day SMA: | 14.82 | Buy |
| 200-day SMA: | 14.36 | Buy |
| 8-day EMA: | 15.11 | Buy |
| 20-day EMA: | 14.98 | Buy |
| 50-day EMA: | 14.81 | Buy |
| 200-day EMA: | 14.44 | Buy |
ASTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.51 | Sell |
| 20-day SMA: | 55.48 | Sell |
| 50-day SMA: | 55.12 | Sell |
| 200-day SMA: | 45.28 | Sell |
| 8-day EMA: | 50.74 | Sell |
| 20-day EMA: | 53.85 | Sell |
| 50-day EMA: | 53.99 | Sell |
| 200-day EMA: | 46.89 | Sell |
Nuveen Dow 30sm Dynamic Overwrite Fund Earnings Growth & DIAX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astrana Health Earnings Growth & ASTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.13 per share.
Nuveen Dow 30sm Dynamic Overwrite Fund Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Astrana Health Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||